Method Development of Orlistat Forced Degradation Sample using MaxPeak™ Premier Columns and QDa™ Mass Detection

Applications | 2024 | WatersInstrumentation
LC/MS, LC/SQ
Industries
Pharma & Biopharma
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

Using a Systematic Screening Protocol and MaxPeak™ HPS Technology to Develop a UHPLC Method for the Analysis of Deferoxamine and its Forced Degradation Products
Method Development of Proteolysis Targeting Chimera (PROTAC) Compound ARV-825 Forced Degradation Sample Using the Systematic Screening Protocol
Using the Systematic Screening Protocol and MaxPeak™ Premier Columns to Separate Seven Janus Kinase Inhibitors
Fast LC Method Development of Spice Cannabinoids Using MaxPeak™ Premier Columns and a Systematic Screening Approach